Therapy News and Research

RSS

FDA approves Brintellix drug to treat depressive disorder in adults

The U.S. Food and Drug Administration today approved Brintellix (vortioxetine) to treat adults with major depressive disorder.

1 Oct 2013

Study shows young patients are at highest risk of colorectal cancer progression, death

Younger patients with colorectal cancer that has spread to other parts of the body represent a high-risk group that is less likely to respond to treatment. Colorectal cancer in patients younger than 40 is more likely to grow despite treatment and young patients are at greater risk of death than people in other age groups.

1 Oct 2013

Biomedical professor receives 2013 Transformative Research Award from NIH

Cancer researchers have been limited by current imaging technology in their ability to detect not only structure and function of tumors, but also tumor cell circulation. A technology proposed by Lihong Wang, PhD, at Washington University in St. Louis, may hold the key to reaching this goal.

1 Oct 2013

Intercalated erlotinib/chemotherapy shows mixed results in NSCLC

A study comparing erlotinib alone with erlotinib intercalated with chemotherapy has failed to demonstrate a clear advantage of the combination strategy when used to treat relapsed patients with non-small-cell lung cancer, Dutch researchers report.

30 Sep 2013

Central BP achieves the same with less

Using central, rather than brachial, blood pressure (BP) to guide treatment decisions results in patients with hypertension being given less medication, show results from a randomized trial.

30 Sep 2013

Researchers discover how aspirin improves survival in patients with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress heard today (Monday).

30 Sep 2013

Stem cell-enriched fat grafting may prove an attractive option to major tissue augmentation

Stem cell-enriched fat grafting could become central to plastic and reconstructive surgery after the first randomised trial in humans confirms the technique’s excellent feasibility and safety.

30 Sep 2013

Women with recurrent ovarian cancer survive longer after treatment with cediranib

Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented today (Monday) at the 2013 European Cancer Congress.

30 Sep 2013

Discovery provides additional key insights into the biology of Multiple Sclerosis

A Griffith University medical scientist is part of an international team which has made a key discovery in the effort to find the cause and cure of Multiple Sclerosis.

30 Sep 2013

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis.

30 Sep 2013

Study examines new method for beating PTSD related to childhood sexual abuse

A new method for overcoming post-traumatic stress disorder related to childhood sexual abuse has been tested and findings are published in the current issue of Psychotherapy and Psychosomatics.

30 Sep 2013

Minimally invasive treatments for lumbar spinal stenosis: an interview with James Corbett, President & Chief Executive Officer of Vertos Medical

Lumbar spinal stenosis (LSS) is a degenerative, age-related narrowing of the lower spinal canal that causes pressure on the nerves, leading to pain and reduced mobility. Symptoms include pain, numbness, or tingling in the lower back, legs, or buttocks, which limits your ability to stand or walk.

30 Sep 2013

Biology of tumour more important than primary site, say researchers

Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress, will hear on Monday.

30 Sep 2013

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers.

30 Sep 2013

AMGEN announces additional results from talimogene laherparepvec Phase 3 trial

AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).

30 Sep 2013

New treatment methods aim to help people reduce binge-eating behavior

Two new treatment methods under investigation at Drexel University aim to help people reduce binge-eating behavior.

30 Sep 2013

Colorectal cancer in younger people appears to be more aggressive

Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.

29 Sep 2013

First Phase II study: Everolimus drug slows spread of advanced papillary kidney cancer

The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress.

29 Sep 2013

Doing yoga during menopause linked to less insomnia

Taking a 12-week yoga class and practicing at home was linked to less insomnia-but not to fewer or less bothersome hot flashes or night sweats. The link between yoga and better sleep was the only statistically significant finding in this MsFLASH (Menopause Strategies: Finding Lasting Answers for Symptoms and Health) Network randomized controlled trial.

29 Sep 2013

c-Fos oncogene cab be important target for understanding and treatment of cancer

The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation-conversion from one cell type to another-or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer.

29 Sep 2013

Therapy News and Research

FDA approves Brintellix drug to treat depressive disorder in adults

Study shows young patients are at highest risk of colorectal cancer progression, death

Biomedical professor receives 2013 Transformative Research Award from NIH

Intercalated erlotinib/chemotherapy shows mixed results in NSCLC

Central BP achieves the same with less

Researchers discover how aspirin improves survival in patients with colon cancer

Stem cell-enriched fat grafting may prove an attractive option to major tissue augmentation

Women with recurrent ovarian cancer survive longer after treatment with cediranib

Discovery provides additional key insights into the biology of Multiple Sclerosis

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

Study examines new method for beating PTSD related to childhood sexual abuse

Minimally invasive treatments for lumbar spinal stenosis: an interview with James Corbett, President & Chief Executive Officer of Vertos Medical

Biology of tumour more important than primary site, say researchers

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

AMGEN announces additional results from talimogene laherparepvec Phase 3 trial

New treatment methods aim to help people reduce binge-eating behavior

Colorectal cancer in younger people appears to be more aggressive

First Phase II study: Everolimus drug slows spread of advanced papillary kidney cancer

Doing yoga during menopause linked to less insomnia

c-Fos oncogene cab be important target for understanding and treatment of cancer

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News